201 related articles for article (PubMed ID: 11400139)
21. Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo.
Newman KD; Elamanchili P; Kwon GS; Samuel J
J Biomed Mater Res; 2002 Jun; 60(3):480-6. PubMed ID: 11920673
[TBL] [Abstract][Full Text] [Related]
22. Degradation kinetics of methacrylated dextrans in aqueous solution.
van Dijk-Wolthuis WN; van Steenbergen MJ; Underberg WJ; Hennink WE
J Pharm Sci; 1997 Apr; 86(4):413-7. PubMed ID: 9109041
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats.
Peters T; Kim SW; Castro V; Stingl K; Strasser T; Bolz S; Schraermeyer U; Mihov G; Zong M; Andres-Guerrero V; Herrero Vanrell R; Dias AA; Cameron NR; Zrenner E
Biomaterials; 2017 Apr; 124():157-168. PubMed ID: 28199885
[TBL] [Abstract][Full Text] [Related]
24. High bioavailabilty of alpha-tocopherol loaded into poly (DL-lactic-co-glycolic acid) microspheres in apolipoprotein B knockout mice.
Yokogawa K; Shima Y; Hashimoto T; Hiyajyo M; Kadoyama K; Ishizaki J; Nomura M; Miyamoto K
Pharm Res; 2003 Nov; 20(11):1846-50. PubMed ID: 14661931
[TBL] [Abstract][Full Text] [Related]
25. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.
Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD
Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
[TBL] [Abstract][Full Text] [Related]
27. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.
Hirota K; Hasegawa T; Hinata H; Ito F; Inagawa H; Kochi C; Soma G; Makino K; Terada H
J Control Release; 2007 May; 119(1):69-76. PubMed ID: 17335927
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of the biomaterials 3wt%-nanostrontium-hydroxyapatite-enhanced calcium phosphate cement (nanoSr-CPC) and nanoSr-CPC-incorporated simvastatin-loaded poly(lactic-co-glycolic-acid) microspheres in osteogenesis improvement: An explorative multi-phase experimental in vitro/vivo study.
Masaeli R; Jafarzadeh Kashi TS; Dinarvand R; Rakhshan V; Shahoon H; Hooshmand B; Mashhadi Abbas F; Raz M; Rajabnejad A; Eslami H; Khoshroo K; Tahriri M; Tayebi L
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():171-83. PubMed ID: 27612702
[TBL] [Abstract][Full Text] [Related]
29. High tolerated paclitaxel nano-formulation delivered by poly (lactic-co-glycolic acid)-g-dextran micelles to efficient cancer therapy.
Liu P; Situ JQ; Li WS; Shan CL; You J; Yuan H; Hu FQ; Du YZ
Nanomedicine; 2015 May; 11(4):855-66. PubMed ID: 25725489
[TBL] [Abstract][Full Text] [Related]
30. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition.
Park TG
Biomaterials; 1995 Oct; 16(15):1123-30. PubMed ID: 8562787
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product.
Kauffman KJ; Do C; Sharma S; Gallovic MD; Bachelder EM; Ainslie KM
ACS Appl Mater Interfaces; 2012 Aug; 4(8):4149-55. PubMed ID: 22833690
[TBL] [Abstract][Full Text] [Related]
32. Migration studies and histology of injectable microspheres of different sizes in mice.
Lemperle G; Morhenn VB; Pestonjamasp V; Gallo RL
Plast Reconstr Surg; 2004 Apr; 113(5):1380-90. PubMed ID: 15060350
[TBL] [Abstract][Full Text] [Related]
33. Poly(lactic-co-glycolic acid) microspheres as a potential bulking agent for urological injection therapy: preliminary results.
Cho ER; Kang SW; Kim BS
J Biomed Mater Res B Appl Biomater; 2005 Jan; 72(1):166-72. PubMed ID: 15449255
[TBL] [Abstract][Full Text] [Related]
34. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
[TBL] [Abstract][Full Text] [Related]
35. Poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for cartilage tissue engineering.
Kang SW; Jeon O; Kim BS
Tissue Eng; 2005; 11(3-4):438-47. PubMed ID: 15869422
[TBL] [Abstract][Full Text] [Related]
36. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery.
Wang D; Robinson DR; Kwon GS; Samuel J
J Control Release; 1999 Jan; 57(1):9-18. PubMed ID: 9863034
[TBL] [Abstract][Full Text] [Related]
37. The dosage effects of dexamethasone on osteogenic activity andbiocompatibility of poly(lactic-co-glycolic acid)/hydroxyapatite nanofibers.
Li C; Wang B; Liu X; Pan Z; Liu C; Ma H; Liu X; Liu L; Jiang C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1823-1832. PubMed ID: 31066304
[TBL] [Abstract][Full Text] [Related]
38. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
39. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres.
Wei G; Pettway GJ; McCauley LK; Ma PX
Biomaterials; 2004 Jan; 25(2):345-52. PubMed ID: 14585722
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
